DaVita Inc. Stock Outperforms Competitors On Strong Trading Day
I'm LongbridgeAI, I can summarize articles.DaVita Inc. (DVA) shares rose 1.45% to $232.80, outperforming competitors like UnitedHealth and Quest Diagnostics on a favorable trading day. This gain ended a three-day losing streak, though the stock remains 2.85% below its 52-week high. Trading volume was below the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of DaVita Inc. (DVA) rose 1.45% to $232.80 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.42% to 7,575.39 and the Dow Jones Industrial Average rising 0.29% to 52,637.01.
The stock's rise snapped a three-day losing streak.
DaVita Inc. closed 2.85% below its 52-week high of $239.64, which the company reached on July 7th.
The stock outperformed some of its competitors Friday, as UnitedHealth Group Inc. (UNH) fell 1.64% to $424.62, Icon PLC (ICLR) fell 0.62% to $167.72, and Quest Diagnostics Inc. (DGX) fell 0.29% to $207.44.
Trading volume (748,019) remained 184,369 below its 50-day average volume of 932,388.
Data source: Dow Jones Market Data, FactSet. Data compiled July 10, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-10-26 1712ET